Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Guidelines search
Search Guidelines
Guidelines search
Apply
Open
Close
Archived Guidelines
(1)
Guidance for COVID-19 and People With HIV
(2)
Guidelines for Caring for Persons With HIV in Disaster Areas
(4)
HIV Clinical Guidelines: Adult and Adolescent ARV
(19)
HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections
(34)
HIV Clinical Guidelines: Pediatric ARV
(19)
HIV Clinical Guidelines: Pediatric Opportunistic Infections
(29)
Perinatal HIV Clinical Guidelines
(18)
Search Results
141 – 160
of
373
Discontinuation or Interruption of Antiretroviral Therapy
Cryptosporidiosis
Cystoisosporiasis (Formerly Isosporiasis)
Fixed-Dose Combinations
Etravirine (Intelence, ETR)
Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)
Zidovudine
Figures
Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs
Toxoplasma gondii Encephalitis
Pharmacoenhancers
Ritonavir (Norvir, RTV)
Pregnancy and Postpartum HIV Testing and Identification of Perinatal and Postnatal HIV Exposure
Overview
Indinavir
Tests for Initial Assessment and Monitoring of People with HIV
Special Patient Populations
Special Populations: Substance Use Disorders and HIV
Tables
Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections
Pagination
First page
‹‹
Previous page
‹
…
Page
6
Page
7
Current page
8
Page
9
Page
10
…
Next page
›
Last page
››